Pacific Edge Limited (PFGTF)
USD 0.06
(-22.13%)
USD 0.06
(-22.13%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 2.73 Million NZD | 0.0% |
| 2023 | 439.05 Thousand NZD | -52.04% |
| 2022 | 915.54 Thousand NZD | -48.56% |
| 2021 | 1.78 Million NZD | 211.73% |
| 2020 | 571 Thousand NZD | 2520.47% |
| 2019 | 21.79 Thousand USD | 15.84% |
| 2018 | 18.81 Thousand USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - NZD | 0.0% |
| 2014 | - NZD | 0.0% |
| 2013 | - NZD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 1.58 Million USD | 0.0% |
| 2024 Q4 | 2.73 Million USD | 0.0% |
| 2024 Q1 | 542.59 Thousand USD | 0.0% |
| 2024 FY | 2.73 Million NZD | 522.97% |
| 2024 Q2 | 529.88 Thousand USD | 0.0% |
| 2023 Q3 | 260.98 Thousand USD | -29.74% |
| 2023 FY | 439.05 Thousand NZD | -52.04% |
| 2023 Q4 | 439.05 Thousand NZD | 68.23% |
| 2023 Q2 | 371.44 Thousand USD | 0.0% |
| 2022 FY | 915.54 Thousand NZD | -48.56% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 FY | 1.78 Million NZD | 211.73% |
| 2021 Q2 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | 571 Thousand NZD | 2520.47% |
| 2020 Q2 | - USD | 0.0% |
| 2019 FY | 21.79 Thousand USD | 15.84% |
| 2018 FY | 18.81 Thousand USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| 2014 FY | - NZD | 0.0% |
| 2013 FY | - NZD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -45486.683% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -110.803% |
| Biocept, Inc. | 10.37 Million USD | 73.637% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 94.669% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 95.533% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -400.655% |
| iMD Companies, Inc. | 1.1 Million USD | -147.829% |
| IDenta Corp. | 428.17 Thousand USD | -538.803% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 35.536% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -883.885% |
| NovelStem International Corp. | 3.32 Million USD | 17.728% |
| Optigenex Inc. | 4.42 Million USD | 38.216% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -67.701% |
| Response Genetics, Inc | 4.91 Million USD | 44.384% |
| Rennova Health, Inc. | 359.19 Thousand USD | -661.485% |
| RushNet, Inc. | 4.25 Million USD | 35.678% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -998.254% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -242.568% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -374.547% |
| Todos Medical Ltd. | 33 Million USD | 91.712% |